Skip to main content

Research Studies: Multiple System Atrophy

Currently Enrolling Studies

AMULET: Interventional, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Center Study to Assess the Efficacy, Safety, and Tolerability of Lu AF82122 in Patients with Multiple System Atrophy (MSA)

  • The study is testing a drug called Lu AF82422 to evaluate its efficacy on disease progression in patients with Multiple System Atrophy (MSA).
  • Autonomic symptoms should have been present for no more than 5 years at time of screening
  • Between ages of 40 and 75


For any questions please contact our research manager, Ileana Rubio at (858) 246-2505 or



For more information about our center's research studies, contact our Clinical Research Coordinator:

Aishwarya Niraula